Latest Insider Transactions at Virnet X Holding Corp (VHC)
This section provides a real-time view of insider transactions for Virnet X Holding Corp (VHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of VirnetX Holding Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of VirnetX Holding Corp's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 14
2024
|
Kendall Larsen President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+11.77%
|
-
|
Nov 12
2024
|
Kendall Larsen President & CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
30,000
+28.67%
|
-
|
Nov 12
2024
|
Robert D Short Iii Chief Scientist |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+48.46%
|
-
|
Nov 12
2024
|
Katherine Allanson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+48.85%
|
-
|
Jun 16
2024
|
Gary Feiner |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+40.0%
|
-
|
Jun 16
2024
|
Thomas M O'Brien |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+27.44%
|
-
|
Jun 16
2024
|
Michael F Angelo |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+33.58%
|
-
|
Jun 16
2024
|
Heidy Kingwan Chow |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+50.0%
|
-
|
May 24
2024
|
Kendall Larsen President & CEO |
BUY
Open market or private purchase
|
Indirect |
1,000
+2.19%
|
$4,000
$4.14 P/Share
|
May 23
2024
|
Kendall Larsen President & CEO |
BUY
Open market or private purchase
|
Indirect |
1,875
+4.12%
|
$7,500
$4.65 P/Share
|
May 22
2024
|
Kendall Larsen President & CEO |
BUY
Open market or private purchase
|
Indirect |
2
+0.0%
|
$8
$4.65 P/Share
|
May 21
2024
|
Kendall Larsen President & CEO |
BUY
Open market or private purchase
|
Indirect |
258
+0.61%
|
$1,032
$4.65 P/Share
|
Jan 31
2024
|
Darl C Mcbride Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,135
-26.79%
|
$12,810
$6.49 P/Share
|
Jan 01
2024
|
Darl C Mcbride Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+42.95%
|
-
|
Jul 05
2023
|
Robert D Short Iii Chief Scientist |
BUY
Grant, award, or other acquisition
|
Direct |
28,150
+31.4%
|
-
|
Jul 05
2023
|
Katherine Allanson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,150
+50.0%
|
-
|
Jul 05
2023
|
Kendall Larsen President & CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
28,150
+3.28%
|
-
|
Jul 05
2023
|
Kendall Larsen President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
56,300
+0.86%
|
-
|
Jun 15
2023
|
Michael F Angelo |
BUY
Grant, award, or other acquisition
|
Direct |
8,333
+5.37%
|
-
|
Jun 15
2023
|
Gary Feiner |
BUY
Grant, award, or other acquisition
|
Direct |
8,333
+10.0%
|
-
|
Jun 15
2023
|
Thomas M O'Brien |
BUY
Grant, award, or other acquisition
|
Direct |
8,333
+3.27%
|
-
|
Jun 05
2023
|
Kendall Larsen President & CEO |
BUY
Open market or private purchase
|
Indirect |
27,974
+3.37%
|
$0
$0.38 P/Share
|
May 26
2023
|
Kendall Larsen President & CEO |
BUY
Open market or private purchase
|
Indirect |
2,000
+0.26%
|
$0
$0.43 P/Share
|
May 25
2023
|
Michael F Angelo |
BUY
Open market or private purchase
|
Direct |
23,000
+14.25%
|
$0
$0.43 P/Share
|
May 18
2023
|
Kendall Larsen President & CEO |
BUY
Open market or private purchase
|
Indirect |
104,166
+11.89%
|
$0
$0.45 P/Share
|
May 18
2023
|
Thomas M O'Brien |
BUY
Open market or private purchase
|
Direct |
50,000
+17.34%
|
$0
$0.42 P/Share
|
Jun 07
2022
|
Kendall Larsen President & CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
13,336
+1.96%
|
-
|
Jun 07
2022
|
Kendall Larsen President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
26,668
+0.41%
|
-
|
Jun 07
2022
|
Robert D Short Iii Chief Scientist |
BUY
Grant, award, or other acquisition
|
Direct |
13,336
+22.22%
|
-
|
Jun 03
2022
|
Michael F Angelo |
BUY
Grant, award, or other acquisition
|
Direct |
8,333
+6.74%
|
-
|
Jun 03
2022
|
Gary Feiner |
BUY
Grant, award, or other acquisition
|
Direct |
8,333
+11.11%
|
-
|
Jun 03
2022
|
Thomas M O'Brien |
BUY
Grant, award, or other acquisition
|
Direct |
8,333
+4.24%
|
-
|
May 25
2022
|
Kendall Larsen President & CEO |
BUY
Open market or private purchase
|
Indirect |
1,870
+0.28%
|
$1,870
$1.13 P/Share
|
May 24
2022
|
Kendall Larsen President & CEO |
BUY
Open market or private purchase
|
Indirect |
13,829
+2.07%
|
$13,829
$1.2 P/Share
|
May 23
2022
|
Kendall Larsen President & CEO |
BUY
Open market or private purchase
|
Indirect |
2,431
+0.38%
|
$2,431
$1.2 P/Share
|
May 20
2022
|
Kendall Larsen President & CEO |
BUY
Open market or private purchase
|
Indirect |
40,650
+6.0%
|
$40,650
$1.2 P/Share
|
Nov 29
2021
|
Kendall Larsen President & CEO |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.83%
|
$10,000
$2.67 P/Share
|
Nov 24
2021
|
Kendall Larsen President & CEO |
BUY
Open market or private purchase
|
Indirect |
20,000
+3.27%
|
$40,000
$2.92 P/Share
|
Nov 23
2021
|
Kendall Larsen President & CEO |
BUY
Open market or private purchase
|
Indirect |
7,759
+1.34%
|
$15,518
$2.82 P/Share
|
Jun 14
2021
|
Kendall Larsen President & CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
13,333
+2.31%
|
-
|
Jun 14
2021
|
Kendall Larsen President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
26,667
+0.41%
|
-
|
Jun 14
2021
|
Richard H Nance Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,666
+14.13%
|
-
|
Jun 14
2021
|
Robert D Short Iii Chief Scientist |
BUY
Grant, award, or other acquisition
|
Direct |
13,333
+9.03%
|
-
|
Jun 03
2021
|
Robert D Short Iii Chief Scientist |
SELL
Payment of exercise price or tax liability
|
Direct |
883
-2.58%
|
$3,532
$4.81 P/Share
|
Jun 03
2021
|
Michael F Angelo |
BUY
Grant, award, or other acquisition
|
Direct |
8,333
+7.22%
|
-
|
Jun 03
2021
|
Gary Feiner |
BUY
Grant, award, or other acquisition
|
Direct |
8,333
+12.5%
|
-
|
Jun 03
2021
|
Thomas M O'Brien |
BUY
Grant, award, or other acquisition
|
Direct |
8,333
+4.42%
|
-
|
Jun 02
2021
|
Robert D Short Iii Chief Scientist |
SELL
Payment of exercise price or tax liability
|
Direct |
884
-2.52%
|
$3,536
$4.81 P/Share
|
Jun 01
2021
|
Robert D Short Iii Chief Scientist |
SELL
Payment of exercise price or tax liability
|
Direct |
1,766
-4.79%
|
$7,064
$4.81 P/Share
|